Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides.
Cathelicidins are a novel family of antimicrobial peptide precursors from mammalian myeloid cells. They are characterized by a conserved N-terminal region while the C-terminal antimicrobial domain can vary considerably in both primary sequence and length. Four cathelicidins, proBac5, proBac7, prododecapeptide and proBMAP-28, have been concurrently purified from bovine neutrophils, using simple and rapid methodologies. The correlation of ES-MS data from the purified proteins with their cDNA-deduced sequences has revealed several common features of their primary sequence, such as the presence of N-terminal 5-oxoproline (pyroglutamate) residues and two disulfide bridges in a 1-2, 3-4 arrangement. The N-terminal domains of the cathelicidins present one or two Asp-Pro bonds, which are particularly acid-labile in proBac5 and proBac7, but stable in prododecapeptide. This suggests that the spatial organization around these bonds may vary in different cathelicidins, and favour hydrolysis in some cases. An unexpected feature of the prododecapeptide is that it exists as dimers formed by three possible combinations of its two isoforms. The isolation of a truncated, monomeric form of this protein, lacking the cysteine-containing antimicrobial dodecapeptide, indicates that dimerization occurs via disulfide bridge formation at the level of the C-terminal domain and that the dodecapeptide is likely released as a dimer from its precursor. Sequence-based secondary structure predictions and CD results indicate for cathelicidins a 30-50% content of extended conformation and <20% content of alpha-helical conformation, with the alpha-helical segment placed near the N-terminus. Finally, similarity searching and topology-based structure prediction underline a significant sequential and structural similarity between the conserved N-terminal domain of cathelicidins and cystatin-like domains, placing this family within the cystatin superfamily. When assayed against cathepsin L, unlike the potent cystatin inhibitors, three of the four cathelicidins show only a poor inhibitory activity (Ki = 0.6-3 microM).
Storici
P
P
Dipartimento di Biochimica, Biofisica e Chimica delle Macromolecole, Università di Trieste, Italy.
Tossi
A
A
Lenarcic
B
B
Romeo
D
D
D000595:Amino Acid Sequence; D000818:Animals; D000890:Anti-Infective Agents; D001798:Blood Proteins / Q000737:chemistry* / Q000302:isolation & purification* / Q000494:pharmacology; D056668:Cathepsin L; D002403:Cathepsins / Q000037:antagonists & inhibitors; D002417:Cattle; D002942:Circular Dichroism; D017124:Conserved Sequence; D003545:Cysteine / Q000737:chemistry; D003546:Cysteine Endopeptidases; D004220:Disulfides / Q000737:chemistry; D010450:Endopeptidases; D007704:Kininogens / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000737:chemistry; D010206:Papain / Q000037:antagonists & inhibitors; D011487:Protein Conformation; D011498:Protein Precursors / Q000737:chemistry* / Q000302:isolation & purification; D011499:Protein Processing, Post-Translational; D017386:Sequence Homology, Amino Acid
D000890:Anti-Infective Agents; D001798:Blood Proteins; D004220:Disulfides; D007704:Kininogens; D011498:Protein Precursors; D002403:Cathepsins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; D056668:Cathepsin L; D010206:Papain; D003545:Cysteine